Vertex Pharmaceuticals Just Made a Major Move: Is the Stock a Buy?
Vertex Pharmaceuticals just made aBold move that could reshape its growth trajectory. This guide breaks down the deal...
Check which passive funds beat the market in 2024 retirement planning and what factors contributed to their outperformance.
28,482 articlesVertex Pharmaceuticals just made aBold move that could reshape its growth trajectory. This guide breaks down the deal...
Investors gauge SpaceX’s potential public listing amid a cautious IPO market. History from Meta’s debut suggests hype...
SoFi’s stock faced a sharp pullback in January. This article breaks down the factors behind the move, what it signals...
IBM faces a tougher 2026 as AI and cloud shifts hit margins. With a sharp price drop and a sizable upside versus cons...
Geopolitical risk in the Middle East is reshaping energy markets. Five high-yield energy stocks offer robust dividend...
Ethereum flirted with a major resistance around $2,160 before pulling back toward $2,080. Traders weigh whether this ...
As XRP weathered a months-long retreat, new regulatory wins, steady ETF inflows, and surging on-chain activity are fu...
Six years after Bitcoin endured its COVID-era collapse, the market has staged a dramatic rebound. This piece examines...
Evolution Petroleum Corp reaches a historic 50th consecutive quarterly dividend, delivering a 10.6% yield at a $4.50 ...
Raymond James raises Marathon's target to 270, driven by sustained refining margins and strong MPLX distributions. MP...
Tesla stock jumps about 19% in the past month, renewing the old Sell in May debate as summer trading looms and moment...
Cardano’s ADA hovers around 26 cents as large holders bolster their positions. While the token remains down about 70%...